2.2. Synthetic procedure for compound 3
1H, C=CH). 11.92 (d, J = 8.0 Hz, 1H, ArH), 8.12 (bs, 1H,
OH). HR-MS (ESI) (C16H10N2O4) Anal. calcd: 294.0641.
Found: 294.0632.
ACCEPTED MANUSCRIPT
Under the protection of nitrogen, 4-hydroxybenzaldehyde
(2.43 g, 15 mmol) and 4-nitrophenylacetonitrile (1.83 g, 15
mmol) were dissolved in 100 mL of dry dichloromethane with 35 2.4 Synthetic procedure for compound
5
5
1.5 mL of piperidine in the reaction solution. The mixture was
stirred at room temperature for 5 h. The colour of the solution
Under the protection of nitrogen, compound 4 (0.59 g, 2
mmol) with 2-aminopyridine (0.19 g, 2 mmol) were dissolved
in 20 mL of MeOH with five drops of glacial acetic acid as
catalyst. The mixture was stirred and refluxed overnight and
changed to
a
burgundy, accompanying with brown
precipitation. When all of the starting materials disappeared
by the TLC detection, the reaction was stopped and 40 the dark red precipitate appeared. After evaporating the
10 neutralized with 10% of dilute hydrochloric acid. The organic
layer was partitioned and the solution was distilled. The
residue was recrystallized in CHCl3-MeOH and compound 3
solvent under vacuum distillation, the residue was purified
with recrystallization in MeOH. The target compound 5 was
1
obtained as blood-red solid in yield of 83.7%. H NMR (400
1
was obtained as yellowish solid in yield of 87.6%. H NMR
MHz, DMSO-d6), δppm: 10.34 (s, 1H, N=CH), 8.36 (s, 1H,
(400 MHz, CDCl3): δppm: 13.03 (d, J = 12.0 Hz, 2H, ArH), 45 ArH), 8.33 (d, J = 8.0 Hz, 2H, ArH), 8.25 (s, 1H, C=CH),
15 12.83 (s, 1H, C=CH), 12.68 (d, J = 12.0 Hz, 2H, ArH), 12.63
(d, J = 12.0 Hz, 2H, ArH), 11.63 (d, J = 12.0 Hz, 2H, ArH),
9.45 (bs, 1H, OH). MALDI-TOF-MS (C15H10N2O3) calcd for
m/z = 266.0691, found: m/z = 266.0664 (M+).
8.18 (d, J = 8.0 Hz, 1H, ArH), 8.01 (d, J = 8.0 Hz, 2H, ArH),
7.87 (bs, 1H, ArH), 7.34-7.38 (m, 1H, ArH), 7.15(d, J = 12.0
Hz, 1H, ArH), 6.43-6.48 (m, 2H, ArH), 5.89 (bs, 1H, OH). 13
C
NMR (100 MHz, DMSO-d6), δppm: 190.14, 164.28, 159.93,
50 149.54, 147.32, 145.63, 140.88, 137.69, 137.09, 131.35,
126.99, 124.73, 123.32, 120.27, 118.95, 117.86, 112.32,
108.62, 105.68. HR-MS (ESI) (C21H14N4O3) [MH]+: Anal.
calcd: 371.1146(MH+). Found: 371.1189(MH+).
2.3 Synthetic procedure for compound 4
20 In nitrogen atmosphere, compound 3 (2.66 g, 10 mmol) and
urotropin (2.80 g, 20 mmol) were dispersed in 30 mL of
trifluoroacetic acid. The mixture was stirred and refluxed for
12 h. TLC detection suggested the dissapearance of materials.
2.5 MTT Assay
Then trifluoroacetic acid in the reaction system was 55 Methylthiazolyldiphenyl-tetrazolium (MTT) trials were done
25 evaporating by vacuum distillation, and the residues were
further separated and purified by chromatographic silica gel
column (eluent: dichlormethane/petroleum ether = 3:1).
Compound 4 was collected in yield of 46.3% as orange solid.
to determine the toxicity for MCF-7 cancer cells. The
o
Inoculated MCF-7 cancer cells were cultivated at 37 C and
5% CO2 for 24 hours, then 1.0×10-5 M of sample 5 was
tracked in the cells after incubating for 24 h. The fostered
1H NMR (400 MHz, DMSO-d6), δppm: 13.08 (s, 1H, ArH), 60 cells were rinsed by PBS buffer, and continue cultivating for 3
30 13.06 (d, J = 8.0 Hz, 2H, ArH), 13.00 (s, 1H, CHO), 12.93 (d,
J = 8.0 Hz, 1H, ArH), 12.73 (d, J = 8.0 Hz, 2H, ArH), 12.51 (s,
hours, in 0.5 mg/mL MTT-PBS buffer. Further, 100 µL of